Eli Lilly, Redwire head to space to explore next frontier of drug development

After Bristol Myers Squibb’s space odyssey earlier this year, another pharmaceutical major is pushing drug development to the fringes of Earth’s gravitational pull.

Eli Lilly is entering the orbit of Redwire Corporation to test the space infrastructure outfit’s in-space drug manufacturing platform, PIL-BOX, Redwire said in a Monday press release.